Cortexyme (CRTX) Stock Chart & Stock Price History $1.60 +0.06 (+3.90%) As of 08/29/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesTrendsBuy This Stock Cortexyme Stock Price Performance The Cortexyme (CRTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 130.78%, with a year-to-date return of -13.51%. In the past month, the stock has decreased 5.33%, reflecting recent market activity. As of the latest close, Cortexyme traded at $1.54 with a market cap of $46.43 million and volume of 122,311 shares. Five years ago, the stock traded at $43.99, representing a 96.36% decrease over that period. At the time, it had a market cap of $1.29 billion and a volume of 123,688 shares. Receive CRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cortexyme and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance0.00%1 Month Performance-5.33%3 Month Performance+53.85%Year-To-Date Performance-13.51%1 Year Performance+130.78%5 Year Performance-96.36% CRTX Stock Chart for Monday, September, 1, 2025 CRTX Chart by TradingView Cortexyme Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/29/2025$1.56$1.54-1.28%$1.60$1.52122,311 shs$46.43 million08/28/2025$1.60$1.56-2.50%$1.62$1.56131,450 shs$47.04 million08/27/2025$1.58$1.60+1.27%$1.62$1.5881,534 shs$48.24 million08/26/2025$1.63$1.58-3.07%$1.67$1.58106,895 shs$47.64 million08/25/2025$1.63$1.63$1.71$1.58178,502 shs$49.15 million08/22/2025$1.63$1.61-1.23%$1.66$1.6061,949 shs$48.54 million08/21/2025$1.61$1.63+1.24%$1.66$1.5974,395 shs$49.15 million08/20/2025$1.67$1.61-3.59%$1.70$1.60165,300 shs$48.54 million08/19/2025$1.69$1.67-1.18%$1.71$1.6681,632 shs$50.35 million08/18/2025$1.69$1.69$1.76$1.63166,060 shs$50.96 million Get the Latest News and Ratings for CRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cortexyme and its competitors with MarketBeat's FREE daily newsletter. 08/15/2025$1.72$1.68-2.33%$1.78$1.66128,177 shs$50.65 million08/14/2025$1.83$1.72-6.01%$1.85$1.72256,720 shs$51.86 million08/13/2025$1.60$1.83+14.38%$1.93$1.56757,533 shs$55.18 million08/12/2025$1.65$1.60-3.03%$1.67$1.53236,137 shs$48.24 million08/11/2025$1.65$1.65$1.69$1.59188,611 shs$49.75 million08/08/2025$1.66$1.67+0.60%$1.70$1.55274,744 shs$50.35 million08/07/2025$1.69$1.66-1.78%$1.72$1.60336,562 shs$50.05 million08/06/2025$1.68$1.69+0.60%$1.75$1.65419,779 shs$50.96 million08/05/2025$1.68$1.68$1.70$1.6361,124 shs$50.65 million08/04/2025$1.68$1.68$1.70$1.6361,124 shs$50.65 million08/01/2025$1.65$1.69+2.42%$1.71$1.62143,878 shs$50.96 million07/31/2025$1.85$1.65-10.81%$1.75$1.64131,075 shs$49.75 million Related Companies Omnicell Stock Price Chart HealthStream Stock Price Chart Veradigm Stock Price Chart Inhibikase Therapeutics Stock Price Chart Protalix BioTherapeutics Stock Price Chart ZIVO Bioscience Stock Price Chart Invizyne Technologies Stock Price Chart CEL-SCI Stock Price Chart JATT Acquisition Stock Price Chart Finch Therapeutics Group Stock Price Chart Receive CRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cortexyme and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CRTX) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredA Major Economic Change Is Happening NowLouis Navellier is one of Wall Street’s most respected money managers — overseeing more than $7 billion and ea...InvestorPlace | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBREAKING: Meta, Apple and NASA rush to invest in new "E.I." techBig Tech and even NASA are racing to back a breakthrough known as “E.I. Tech,” set to launch September 1st. Ex...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cortexyme, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cortexyme With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
